One-year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry.

Elisabetta MoscarellaAlfonso Ielasi Elisabetta Moscarella Bernardo CorteseBruno LoiGiuseppe TarantiniFrancesco PisanoAlessandro DuranteGiampaolo PasquettoAlessandro ColomboGabriele TumminelloLuciano MorettiPaolo CalabròPietro MazzarottoMaurizio TespiliPedro Silva OrregoDonatella CorradoGiuseppe Steffeninonull null

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

Our data suggest that the use of BVS in ACS patients is associated with a numerically higher rate of ScT compared to SCAD population numerically higher, but without statistical significance.

Keyphrases

acute coronary syndrome
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
electronic health record
antiplatelet therapy
percutaneous coronary intervention
patient reported outcomes
deep learning